IP Verse

Polymorphic And Pseudopolymorphic Forms Of Pharmaceutical Compound Nxl104 - EP3269717

PATENT ANALYSIS

Patent Details

Grant Date
Aug 9, 2023
Company
PFIZER IRELAND PHARMACEUTICALS
Oppositions

LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB

More patents of Pfizer Ireland Pharmaceuticals

EP3269717

EP2357250

EP1789571

Want to monitor this patent?

Feel free to send us a message here and we will get back to you